Broad endorsement for insurance-covered blood-based CRC screening (92%) suggests payer policy could materially influence ...

For most people, the biggest obstacle to routine blood testing isn’t fear of needles. It’s the process itself. Traditional lab work often requires booking appointments weeks in advance, rearranging ...

AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) ...

With the approval of anti-amyloid monoclonal antibodies to treat early-stage Alzheimer’s disease (AD), the need for accurate and early diagnosis is crucial. Blood-based biomarkers offer a promising ...

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX), and health care technology company Babson Diagnostics, announced Tuesday an expansion of fingertip blood collection and ...